![]() Read the full story by clicking on this headline.. |
Pfizer Inc said on Thursday its vaccine for respiratory syncytial virus (RSV) was effective among older adults in a late-stage study and it plans to file for approval with the U.S. health regulator in the coming months. There are no U.S. approved vaccines for RSV, a common... |
0 Comments
Leave a Reply. |
NewsMaxA conservative American news and opinion website founded by Christopher Ruddy in 1998 & operated by Newsmax Media. Archives
June 2023
Categories |